Delivery Order SPE2DB20D3101-SPE2DB25FRCE8
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,393.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567064635 - Methylergonovine 0.2 mg/ml vials, with a final completion date of January 29, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,196.66, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract is a Delivery Order (DO) for the supply of 4566548161 - Methylergonovine 0.2 mg/mL, a medication used to treat postpartum hemorrhage. The contract has a firm fixed price and a period of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,347.93 firm fixed-price delivery order is for the supply of 4565150115 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award is between the Defense Logistics Agency (DLA) and Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,358.52, is for the delivery of methylergonovine 0.2 mg tablets to support military and government healthcare needs. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $8,015.37, is for the delivery of 4,558,459,996 tablets of the medication Methylergonovine 0.2 mg. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of September 15, 2022. This award is not associated with a set-aside...
This federal contract award, valued at $1,859.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567118669 - Methylergonovine 0.2 mg/ml vial. This is a Firm Fixed Price Delivery Order contract with a completion date of February 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4,563,032,696 units of the pharmaceutical drug Methylergonovine 0.2 mg Tablet in 28-count packages. The award has a ceiling value of $21,472.44 and a completion date of December 8, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not...
This federal contract award, valued at $2,873.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4560862324 - Methylergonovine 0.2 mg/ml vials, with a performance period ending on May 9, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566416810 - Methylergonovine 0.2 mg/ml vials, with a ceiling value of $2,881.54 and a period of performance through November 14, 2024. The contract is a firm-fixed-price delivery order and was not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award is for the delivery of 4,566,265 units of Methylergonovine 0.2 mg/ml vials, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The $1,242.55 firm-fixed-price delivery order contract has an ultimate completion date of October 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor and there is no set-aside designation. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held...